Norges Bank’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$35.8M Buy
+983,638
New +$35.8M ﹤0.01% 1071
2025
Q1
Sell
-961,794
Closed -$40.5M 1285
2024
Q4
$40.5M Buy
+961,794
New +$40.5M 0.01% 1042
2024
Q3
Sell
-1,002,463
Closed -$41.2M 1344
2024
Q2
$41.2M Buy
1,002,463
+203,959
+26% +$8.38M 0.01% 978
2024
Q1
$37.3M Buy
798,504
+27,998
+4% +$1.31M 0.01% 1065
2023
Q4
$36.8M Buy
770,506
+172,418
+29% +$8.25M 0.01% 1043
2023
Q3
$21.3M Hold
598,088
﹤0.01% 1209
2023
Q2
$27.6M Sell
598,088
-75,604
-11% -$3.49M 0.01% 1116
2023
Q1
$27M Sell
673,692
-49,940
-7% -$2M 0.01% 1130
2022
Q4
$33.5M Sell
723,632
-41,488
-5% -$1.92M 0.01% 1007
2022
Q3
$31.7M Buy
765,120
+95,850
+14% +$3.97M 0.01% 974
2022
Q2
$39.9M Buy
669,270
+6,594
+1% +$393K 0.01% 878
2022
Q1
$48.1M Buy
662,676
+41,100
+7% +$2.98M 0.01% 905
2021
Q4
$52.3M Buy
621,576
+59,038
+10% +$4.96M 0.01% 914
2021
Q3
$50.7M Sell
562,538
-41,800
-7% -$3.77M 0.01% 917
2021
Q2
$57.6M Buy
604,338
+59,885
+11% +$5.71M 0.01% 886
2021
Q1
$62M Sell
544,453
-14,990
-3% -$1.71M 0.01% 855
2020
Q4
$77.4M Buy
559,443
+84,621
+18% +$11.7M 0.02% 715
2020
Q3
$39M Sell
474,822
-532
-0.1% -$43.7K 0.01% 977
2020
Q2
$37.2M Sell
475,354
-37,210
-7% -$2.91M 0.01% 1043
2020
Q1
$22.8M Hold
512,564
0.01% 1164
2019
Q4
$21.9M Hold
512,564
0.01% 1474
2019
Q3
$21.9M Buy
512,564
+28,058
+6% +$1.2M 0.01% 1429
2019
Q2
$30.8M Buy
484,506
+43,999
+10% +$2.79M 0.01% 1212
2019
Q1
$30.6M Buy
440,507
+71,429
+19% +$4.95M 0.01% 1197
2018
Q4
$16M Buy
369,078
+43,564
+13% +$1.89M 0.01% 1532
2018
Q3
$24.9M Sell
325,514
-230,880
-41% -$17.6M 0.01% 1399
2018
Q2
$42.8M Sell
556,394
-295,859
-35% -$22.7M 0.01% 960
2018
Q1
$43.5M Buy
852,253
+323,723
+61% +$16.5M 0.02% 882
2017
Q4
$24.5M Hold
528,530
0.01% 1339
2017
Q3
$28.2M Hold
528,530
0.01% 1209
2017
Q2
$32.8M Buy
528,530
+79,815
+18% +$4.96M 0.01% 1041
2017
Q1
$30.4M Sell
448,715
-73,500
-14% -$4.98M 0.01% 1076
2016
Q4
$36.7M Hold
522,215
0.02% 869
2016
Q3
$35.4M Buy
522,215
+230,426
+79% +$15.6M 0.02% 828
2016
Q2
$14.3M Sell
291,789
-14,800
-5% -$724K 0.01% 1409
2016
Q1
$19.4M Hold
306,589
0.01% 1175
2015
Q4
$34.4M Buy
306,589
+11,367
+4% +$1.28M 0.02% 802
2015
Q3
$28.4M Buy
295,222
+49,577
+20% +$4.77M 0.01% 903
2015
Q2
$25.2M Buy
245,645
+223,645
+1,017% +$22.9M 0.01% 1053
2015
Q1
$1.37M Buy
+22,000
New +$1.37M ﹤0.01% 2126